| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
|
N Engl J Med
|
2002
|
101.79
|
|
2
|
Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.
|
Implement Sci
|
2009
|
21.66
|
|
3
|
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
|
J Natl Cancer Inst
|
1989
|
19.87
|
|
4
|
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
16.52
|
|
5
|
Colorectal cancer statistics, 2014.
|
CA Cancer J Clin
|
2014
|
12.86
|
|
6
|
Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample.
|
Ann Intern Med
|
2004
|
6.86
|
|
7
|
Rare and common variants: twenty arguments.
|
Nat Rev Genet
|
2012
|
6.67
|
|
8
|
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses.
|
Lancet
|
2010
|
6.07
|
|
9
|
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
|
Circulation
|
2014
|
4.56
|
|
10
|
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).
|
J Am Coll Cardiol
|
2002
|
4.48
|
|
11
|
Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use.
|
Arch Intern Med
|
2000
|
4.11
|
|
12
|
Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls.
|
Nat Biotechnol
|
2014
|
4.07
|
|
13
|
Projecting individualized absolute invasive breast cancer risk in African American women.
|
J Natl Cancer Inst
|
2007
|
3.93
|
|
14
|
Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.
|
Med Care
|
2012
|
3.85
|
|
15
|
An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team.
|
JAMA
|
1993
|
3.65
|
|
16
|
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
|
JAMA
|
2016
|
3.48
|
|
17
|
Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes.
|
J Gen Intern Med
|
2012
|
3.42
|
|
18
|
Smoking and colorectal cancer: a meta-analysis.
|
JAMA
|
2008
|
3.19
|
|
19
|
Association of Admission to Veterans Affairs Hospitals vs Non-Veterans Affairs Hospitals With Mortality and Readmission Rates Among Older Men Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia.
|
JAMA
|
2016
|
2.92
|
|
20
|
A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
|
Nat Genet
|
2015
|
2.84
|
|
21
|
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.
|
Ann Intern Med
|
2015
|
2.67
|
|
22
|
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
|
Ann Intern Med
|
2013
|
2.53
|
|
23
|
Polygenic type 2 diabetes prediction at the limit of common variant detection.
|
Diabetes
|
2014
|
2.52
|
|
24
|
Carcinogenicity of consumption of red and processed meat.
|
Lancet Oncol
|
2015
|
2.51
|
|
25
|
Obesity prevalence among veterans at Veterans Affairs medical facilities.
|
Am J Prev Med
|
2005
|
2.40
|
|
26
|
Genomics. Deflating the genomic bubble.
|
Science
|
2011
|
2.20
|
|
27
|
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
|
Value Health
|
2013
|
2.20
|
|
28
|
The PRECIS-2 tool: designing trials that are fit for purpose.
|
BMJ
|
2015
|
2.12
|
|
29
|
Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis.
|
J Am Coll Cardiol
|
2014
|
2.03
|
|
30
|
A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen.
|
Clin Trials
|
2011
|
1.91
|
|
31
|
A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.
|
Eur Urol
|
2014
|
1.79
|
|
32
|
A genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study.
|
Diabetologia
|
2012
|
1.73
|
|
33
|
Healthcare costs associated with prostate cancer: estimates from a population-based study.
|
BJU Int
|
2009
|
1.62
|
|
34
|
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.
|
Trials
|
2014
|
1.62
|
|
35
|
Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12).
|
Qual Life Res
|
2008
|
1.60
|
|
36
|
Measuring missing heritability: inferring the contribution of common variants.
|
Proc Natl Acad Sci U S A
|
2014
|
1.58
|
|
37
|
Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing.
|
Med Decis Making
|
2012
|
1.57
|
|
38
|
Smoking prevalence among US veterans.
|
J Gen Intern Med
|
2009
|
1.50
|
|
39
|
Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial.
|
Diabetes Care
|
2012
|
1.46
|
|
40
|
The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency.
|
Prev Med
|
2006
|
1.44
|
|
41
|
The genetic architecture of type 2 diabetes.
|
Nature
|
2016
|
1.43
|
|
42
|
Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing.
|
J Genet Couns
|
2011
|
1.42
|
|
43
|
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.
|
Am J Hum Genet
|
2016
|
1.35
|
|
44
|
Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update.
|
Genet Med
|
2012
|
1.34
|
|
45
|
Health status assessments using the Veterans SF-12 and SF-36: methods for evaluating otucomes in the Veterans Health Administration.
|
J Ambul Care Manage
|
2001
|
1.32
|
|
46
|
The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
|
BMJ
|
2016
|
1.28
|
|
47
|
Dissemination of methods and results from the veterans health study: final comments and implications for future monitoring strategies within and outside the veterans healthcare system.
|
J Ambul Care Manage
|
2006
|
1.20
|
|
48
|
Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support.
|
J Gen Intern Med
|
2015
|
1.17
|
|
49
|
Physicians' preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system.
|
Genet Test Mol Biomarkers
|
2013
|
1.15
|
|
50
|
MyHealtheVet PHR: a description of users and patient portal use.
|
AMIA Annu Symp Proc
|
2008
|
1.14
|
|
51
|
Implementation of the Department of Veterans Affairs' first point-of-care clinical trial.
|
J Am Med Inform Assoc
|
2012
|
1.14
|
|
52
|
A systematic approach to the reporting of medically relevant findings from whole genome sequencing.
|
BMC Med Genet
|
2014
|
1.14
|
|
53
|
The growing role of professional societies in educating clinicians in genomics.
|
Genet Med
|
2014
|
1.13
|
|
54
|
Are biomarkers useful treatment aids for promoting health behavior change? An empirical review.
|
Am J Prev Med
|
2002
|
1.13
|
|
55
|
How can polygenic inheritance be used in population screening for common diseases?
|
Genet Med
|
2013
|
1.10
|
|
56
|
An improved set of standards for finding cost for cost-effectiveness analysis.
|
Med Care
|
2009
|
1.08
|
|
57
|
Developing and evaluating polygenic risk prediction models for stratified disease prevention.
|
Nat Rev Genet
|
2016
|
1.05
|
|
58
|
Genotype prediction of adult type 2 diabetes from adolescence in a multiracial population.
|
Pediatrics
|
2012
|
1.05
|
|
59
|
When activation changes, what else changes? the relationship between change in patient activation measure (PAM) and employees' health status and health behaviors.
|
Patient Educ Couns
|
2012
|
1.05
|
|
60
|
Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.
|
Genet Med
|
2013
|
1.04
|
|
61
|
Development of phenotype algorithms using electronic medical records and incorporating natural language processing.
|
BMJ
|
2015
|
1.03
|
|
62
|
Next-generation genotype imputation service and methods.
|
Nat Genet
|
2016
|
1.01
|
|
63
|
2. Classification and Diagnosis of Diabetes.
|
Diabetes Care
|
2017
|
1.00
|
|
64
|
Are physicians prepared for whole genome sequencing? a qualitative analysis.
|
Clin Genet
|
2015
|
1.00
|
|
65
|
Educational needs of primary care physicians regarding direct-to-consumer genetic testing.
|
J Genet Couns
|
2011
|
1.00
|
|
66
|
An introduction to implementation science for the non-specialist.
|
BMC Psychol
|
2015
|
0.99
|
|
67
|
An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes.
|
Med Care
|
1999
|
0.99
|
|
68
|
How to know when physicians are ready for genomic medicine.
|
Sci Transl Med
|
2015
|
0.98
|
|
69
|
Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial).
|
Circulation
|
2016
|
0.97
|
|
70
|
Translational research is a key to nongeneticist physicians' genomics education.
|
Genet Med
|
2014
|
0.95
|
|
71
|
Building the Partners HealthCare Biobank at Partners Personalized Medicine: Informed Consent, Return of Research Results, Recruitment Lessons and Operational Considerations.
|
J Pers Med
|
2016
|
0.94
|
|
72
|
Academic family physicians' perception of genetic testing and integration into practice: a CERA study.
|
Fam Med
|
2013
|
0.93
|
|
73
|
'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.
|
Per Med
|
2015
|
0.93
|
|
74
|
Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans.
|
J Gen Intern Med
|
2015
|
0.92
|
|
75
|
A one-page summary report of genome sequencing for the healthy adult.
|
Public Health Genomics
|
2015
|
0.92
|
|
76
|
Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes Prevention.
|
Clin Trials
|
2011
|
0.91
|
|
77
|
An Expanded View of Complex Traits: From Polygenic to Omnigenic.
|
Cell
|
2017
|
0.91
|
|
78
|
Diagnoses of overweight/obesity, active component, U.S. Armed Forces, 1998-2010.
|
MSMR
|
2011
|
0.90
|
|
79
|
Use of a computer decision support system and antimicrobial therapy appropriateness.
|
Infect Control Hosp Epidemiol
|
2013
|
0.88
|
|
80
|
Redesign of a computerized clinical reminder for colorectal cancer screening: a human-computer interaction evaluation.
|
BMC Med Inform Decis Mak
|
2011
|
0.87
|
|
81
|
The Biobank Portal for Partners Personalized Medicine: A Query Tool for Working with Consented Biobank Samples, Genotypes, and Phenotypes Using i2b2.
|
J Pers Med
|
2016
|
0.87
|
|
82
|
Primary care providers' experiences with and perceptions of personalized genomic medicine.
|
Can Fam Physician
|
2016
|
0.86
|
|
83
|
A Simple and Portable Algorithm for Identifying Atrial Fibrillation in the Electronic Medical Record.
|
Am J Cardiol
|
2015
|
0.85
|
|
84
|
A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians.
|
Genet Med
|
2013
|
0.84
|
|
85
|
Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies.
|
Diabetes Res Clin Pract
|
2011
|
0.84
|
|
86
|
Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol: The MEC Study.
|
Am J Epidemiol
|
2015
|
0.83
|
|
87
|
Summarizing polygenic risks for complex diseases in a clinical whole-genome report.
|
Genet Med
|
2014
|
0.83
|
|
88
|
Polygenic Epidemiology.
|
Genet Epidemiol
|
2016
|
0.83
|
|
89
|
Genetic associations with metabolic syndrome and its quantitative traits by race/ethnicity in the United States.
|
Metab Syndr Relat Disord
|
2011
|
0.81
|
|
90
|
Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study.
|
BMC Med Genomics
|
2015
|
0.81
|
|
91
|
Colorectal Cancer Statistics From the Veterans Affairs Central Cancer Registry.
|
Clin Colorectal Cancer
|
2016
|
0.79
|
|
92
|
Stakeholder engagement in policy development: challenges and opportunities for human genomics.
|
Genet Med
|
2015
|
0.78
|
|
93
|
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans.
|
Diabetes
|
2017
|
0.78
|
|
94
|
Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
|
Clin Gastroenterol Hepatol
|
2016
|
0.77
|
|
95
|
Genomic medicine and risk prediction across the disease spectrum.
|
Crit Rev Clin Lab Sci
|
2015
|
0.77
|
|
96
|
Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies.
|
Diabetologia
|
2016
|
0.77
|
|
97
|
Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research.
|
Genet Med
|
2017
|
0.77
|
|
98
|
Implementation science, genomic precision medicine, and improved health: A new path forward?
|
Nurs Outlook
|
2016
|
0.75
|
|
99
|
The current state of implementation science in genomic medicine: opportunities for improvement.
|
Genet Med
|
2017
|
0.75
|
|
100
|
A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system.
|
Genet Med
|
2017
|
0.75
|